Pharmaceutical groups are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. Despite this, accessing, analyzing, and interpreting complex RWD often be https://marvinzlwi630264.blogdigy.com/datma-s-federated-biomarker-explorer-free-effortless-real-world-data-assessment-for-pharma-teams-55389332